Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Leukemia 17Leukemia, Myeloid, Chronic-Phase 16Leukemia, Myeloid, Acute 14Breast Neoplasms 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 10Prostatic Neoplasms 9Neoplasm Metastasis 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 7Blast Crisis 7Pancreatic Neoplasms 6Burkitt Lymphoma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Glioma 5Glioblastoma 5Philadelphia Chromosome 4Myelodysplastic Syndromes 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4Gliosarcoma 4Gastrointestinal Stromal Tumors 4Colorectal Neoplasms 4Waldenstrom Macroglobulinemia 3

Interventions

Geriatric Assessment 12Preoperative Exercise 3epigallocatechin gallate 2Standard of Care 2Observation 2Nutritional Support 2Nutrition Assessment 2Exercise 2Ascorbic Acid 2peflavit 1microcrystalline cellulose 1fisetin 1diacetamate 1cabozantinib 1Ultrasonography 1Tretinoin 1Therapeutics 1Temozolomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Spectroscopy, Near-Infrared 1Restraint, Physical 1Resistance Training 1Quercetin 1Qigong 1Psychosocial Intervention 1Protons 1Photons 1Methods 1Immunonutrition Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Frailty × Dasatinib × Clear all
NCT04733534 2026-04-24

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
110 enrolled

Frailty, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡